TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Indonesia secures vaccine sources amid fiercer competition

Dian Septiari (The Jakarta Post)
Premium
Jakarta
Tue, April 20, 2021

Share This Article

Change Size

Indonesia secures vaccine sources amid fiercer competition A photo taken on March 22 shows vials of AstraZeneca COVID-19 vaccine before being given to residents of Jombang regency, East Java. (Antara/Syaiful Arif)

I

ndonesia has secured enough buy-ins from its partners to provide a steady supply of COVID-19 vaccines for its procurement pipeline, Health Minister Budi Gunadi Sadikin said on Monday, as global competition over the jabs heats up and the gap between rich and poor nations deepens.

Speaking at the vaccination of creative industry workers at the National Gallery in Jakarta, Budi gave an assurance that the country would have enough options to continue its vaccination drive even if global shortages get worse.

“Now the struggle to get vaccines is truly getting fierce all over the world. Thank God that Indonesia has four sources [to choose from],” he said at the public service event, broadcast live by the Presidential Secretariat.

The nation currently sources its vaccine jabs from several producers, including Chinese pharmaceuticals company Sinovac Biotech, Anglo-Swedish drug company AstraZeneca, United States drug developer Novavax and Pfizer-BioNTech, a US-German collaboration.

In the event of disrupted supplies from one manufacturer, the minister insists Indonesia would still be able to rely on the others. The country had hoped to diversify its vaccine supplies, but so far it could only rely on Sinovac.

“The smoothest delivery is from China; they routinely send a shipment every two weeks,” Budi said.

On Sunday, Indonesia received 6 million doses of bulk material for vaccines that will be processed into 4.8 doses set to be distributed in May, he said. The shipment was part of the 140 million bulk vaccines that Indonesia will receive this year from Sinovac.

to Read Full Story

  • Unlimited access to our web and app content
  • e-Post daily digital newspaper
  • No advertisements, no interruptions
  • Privileged access to our events and programs
  • Subscription to our newsletters
or

Purchase access to this article for

We accept

TJP - Visa
TJP - Mastercard
TJP - GoPay

Redirecting you to payment page

Pay per article

Indonesia secures vaccine sources amid fiercer competition

Rp 29,000 / article

1
Create your free account
By proceeding, you consent to the revised Terms of Use, and Privacy Policy.
Already have an account?

2
  • Palmerat Barat No. 142-143
  • Central Jakarta
  • DKI Jakarta
  • Indonesia
  • 10270
  • +6283816779933
2
Total Rp 29,000
{

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.